Latest ArticlesTo evaluate and compare efficacy and safety of recombinant human tumor necrosis factor receptor Ⅱ-immunoglobulin G-Fc fusion protein for injection (rhTNFR-Fc) combined with methotrexate (MTX) and MTX alone in the treatment of active rheumatoid arthritis (RA).
A total of 72 patients with active RA who visited department of rheumatology and immunology, Gaomi people's hospital from July 1, 2021 to July 1, 2022 were selected and divided into combination group and control group according to the order of treatment and random number table method, with 36 cases in each group. Both groups were given MTX orally and the combination group was given rhTNFR-Fc, all patients were treated for 24 weeks. Joint symptoms, inflammatory indicators, efficacy and adverse reactions were compared before and after treatment.
After treatment, the levels of C-reactive protein (2.50 mg/L vs 6.35 mg/L) and erythrocyte sedimentation rate (20.50 mm/h vs 27.50 mm/h) decreased in the two groups, and the differences were statistically significant (P<0.05). There were significant differences in response rates of American College of Rheumatology (ACR)20 (88.89% vs 66.67%), ACR50 (75.00% vs 50.00%) and ACR70 (63.89% vs 38.89%) and disease activity score 28 (2.32 scores vs 2.74 scores) (P<0.05).
RhTNFR-Fc combined with MTX can reduce inflammatory indexes in RA patients with better effect and does not increase the incidence of adverse reactions. It has high safety and clinical application value, and is worthy of further promotion.
To explore the effect of personalized midwifery clinics on improving natural delivery rates and maternal satisfaction.
A total of 230 pregnant women who received personalized midwifery outpatient intervention were randomly selected as the study group from the department of obstetrics, maternal and child health hospital of Songjiang district in Shanghai from October 2020 to June 2021, and 230 pregnant women who did not receive personalized midwifery outpatient intervention were randomly selected as the control group. The basic information and pregnancy outcome of pregnant women were collected, and the outcomes of childbirth and satisfaction with the hospital were compared between the two groups.
There were 157 primiparas (77.72%) and 23 multiparas (82.14%) delivered naturally in the study group, while 133 primiparas (70.74%) and 28 multiparas (66.67%) delivered naturally in the control group. There was a significant difference in the natural delivery rate between the two groups (P<0.05). Among the women who delivered naturally, 118 primiparas (75.16%) and 12 multiparas (52.17%) in the study group delivered naturally were higher than those in the control group 84 primiparas (63.16%) and 10 multiparas (35.17%), and the difference was statistically significant (P<0.05). In the study group, there were 182 primiparas (90.10%) and 23 multiparas (82.14%) were satisfied, while 128 primiparas (68.09%) and 26 multiparas (61.90%) were satisfied in the control group, the difference was statistically significant (P<0.05).
The perinatal personalized midwifery clinic can improve the natural delivery rate, improve the correct perception of delivery, and improve the satisfaction of pregnant women and their families to the hospital. So as to provide reference for the formation of a more standardized and systematic practice model for midwifery clinic s and improve the quality of fertility services.
To explore and analyze the safety signals of irinotecan and fluorouracil.
The adverse drug reaction (ADR) reports with irinotecan and fluorouracil as suspects included in the FDA adverse event reporting system (FAERS) from January 2004 to September 2021 were selected. The ADR signals were detected by reporting odds ratio and proportional reporting signals.
For the primary screening, 583, 1 239 and 674 preferred term (PT) were obtained by irinotecan, fluorouracil and the combination of two drugs, respectively. The top 3 PT in the number of reports of the combination of two drugs were diarrhea (5.88%), neutropenia (3.41%) and nausea (3.26%), respectively. After secondary screening, 28, 70 and 60 PT were obtained by irinotecan, fluorouracil and the combination of two drugs, and 10, 17 and 13 system organ class were involved, respectively. In the double-screened PT cholinergic syndrome, the reporting odds ratio was 127.4 and 95% confidence interval was (82.9, 195.6). By comparing the Venn diagram of primary screening and secondary screening, the overlap of PT with prominent signal was significantly reduced among irinotecan, fluorouracil and the combination of two drugs.
When using single drug, ADR is more prominent.
To understand the incidence of tuberculosis and drug resistance of anti-tuberculosis, and to provide reference for the formulation and implementation of targeted prevention and control measures.
Case information of tuberculosis report card and resident demographic data in Wuyuan county from 2010 to 2021 were obtained from the National Tuberculosis Information Management System and Wuyuan County Bureau of Statistics, respectively. Solid anti-tuberculosis drug sensitivity was applied to test the drug sensitivity condition among the positive sample, and SPSS22.0 software was used for statistical analysis.
From 2010 to 2021, a total of 2 864 tuberculosis cases were reported in Wuyuan county. The annual reported incidence rate of tuberculosis was between 36/100 000 and 89/100 000, with a downward trend year by year. The annual incidence rate in male tuberculosis (52/100 000 - 124/100 000) was slightly higher than that in female tuberculosis (19/100 000 - 52/100 000). The average age of 2 864 tuberculosis patients was (46.41±17.53) years old, the occupation was mainly "farmers/migrant workers"(84.22%), and the "positive" rate of pathogenic diagnosis was 55.69%. The successful treatment rate of 2 864 tuberculosis patients was 91.89% (2 617/2 848). The drug sensitivity test of tuberculosis showed that the overall drug resistance rate was 22.55% (53/235), the multi-drug resistance rate was 10.64%, and the multiple drug resistance rate was 6.38%.
The annual reported incidence rate of tuberculosis in Wuyuan county showed a decreasing trend year by year, but the proportion of drug-resistant tuberculosis patients was relatively high. In future, we should pay more attention to key groups such as men and elderly residents, focus on health education, monitoring and intervention, strictly implement standardized treatment for tuberculosis patients, and reduce the incidence rate of tuberculosis, and anti-tuberculosis drug resistance rate.
Immune checkpoint inhibitors (ICI) have revolutionized the field of cancer treatment. ICI can enhance the antitumor effect, however, it can also induce excessive activation of the immune response, leading to normal tissue damage and trigger immune-related adverse events. In the immunotherapy of non-small cell lung cancer (NSCLC), ICI-related pneumonia (CIP) is rare but has extremely high mortality, it occurs from 7% to 13%. Moreover, with the increased use of ICI in NSCLC, identifying high-risk factors and underlying mechanisms for CIP are key points in preventing and monitoring adverse events. This article reviewed the research progress in the pathogenesis, risk factors, and predictive factors of CIP, in order to improve clinical understanding of the disease and provide reference for patient safety management.
Pyrroloquinoline quinone (PQQ) is a kind of micro substance synthesized by microorganisms, widely distributed in organisms. The content of PQQ in food is 0.19 - 7.2 ng/g, while the content in human body is 5 - 10 times lower than that in food. PQQ plays a variety of physiological roles in mammals, such as anti-inflammatory and antioxidant. PQQ can stimulate mitochondrial generation and cell proliferation, affect reproduction and growth, improve brain function and regulate metabolic diseases. PQQ has a very broad medical and health application prospect, and it was issued as a new food raw material by China National Health Commission in March 2022. This article reviewed the natural distribution, potential role in disease treatment, physiological function and safety of PQQ, and summarized the effects of PQQ on antioxidation, anti-inflammation, stimulating mitochondrial generation, promoting growth and improving cognition, as well as its potential value in the treatment of diabetes, muscular dystrophy and osteoporosis, in order to provide reference for the application and research of PQQ.
The clinical diagnosis and treatment of psoriasis is an important medical problem. In recent years, traditional Chinese medicine has reached a consensus on blood division in the treatment of psoriasis. Closely related to the two pathological factors of "blood heat Yang floating" and "blood stasis", relevant scholars summarized previous experience and put forward the "new blood syndrome theory" for diagnosis and treatment of psoriasis. In the treatment of psoriasis, we pay attention to the application of Jueyin granules and Taodan granules and Tripterygium wilfordii, which enriching and developing the theoretical system of traditional Chinese medicine for psoriasis.
Tumor-infiltrating lymphocytes (TIL) has a high degree of heterogeneity. Adoptive cellular immunotherapy is one of the important treatments of immunotherapy. It is effective in many advanced solid tumors treatment with few adverse reactions through TIL reinfusing after expansion in vitro. TIL also has the the role of the effectiveness of anti-tumor therapy. This article reviewed the clinical research progress of TIL therapy in different types of cancer, the research progress of TIL as a predictor of tumor prognosis, and the problems faced by TIL therapy, in order to provide the evidence for follow-up research and the clinical use of TIL therapy.
Bispecific antibody is an artificial antibody prepared by cell fusion or recombinant DNA technology that can specifically bind two antigens or two different epitopes of the same antigen at the same time. Immune checkpoint inhibitors have revolutionized the treatment paradigm for advanced solid tumors. However, not all types of malignancies respond to these drugs, and the response rate and treatment effect of cancer patients still need to be improved. This article reviewed the current status and progress of clinical research on dual-antibody drugs targeting programmed death ligand 1.
Non-small cell lung cancer (NSCLC) has an insidious onset, and some of the diagnosed cases are already in advanced stage, and most of them adopt platinum-based two-drug palliative chemotherapy regimen, but the safety of chemotherapy regimen is low, and patients often stop/change the drug due to intolerance to the adverse effects. Compound Kushen injection has the function of clearing heat and dampness, cooling blood and detoxifying, expelling nodules to relieve pain. It is widely used in clinical adjuvant treatment of NSCLC, which can help radiotherapy and chemotherapy to combat tumor, regulate tumor markers levels and prolong patients' survival period, as well as alleviate adverse effects, relieve cancer pain, improve patients' immunity and quality of life. This article reviewed the research progress of compound Kushen injection in the adjuvant treatment of NSCLC, to provide some ideas and basis for its application and research in the treatment of NSCLC.